The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results ...

Zealand Pharma A/S (ZLDPF) shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Douglas Pharmaceuticals, New Zealand’s largest privately owned pharmaceutical company, announces the launch of Winlevi® ...

Complete Zealand Pharma A/S stock information by Barron's. View real-time ZLDPF stock price and news, along with industry-best analysis.